New horizons in the pharmacological management of venous thromboembolism
Abstract Many patients suffer from venous thromboembolism (VTE) and its consequences. Despite substantial advancements with the introduction of direct oral anticoagulants (DOACs), patients and clinicians still encounter challenges in the acute and long‐term management of VTE, such as recurrent event...
Saved in:
| Main Authors: | Andreas Verstraete, Quentin Van Thillo, Thomas Vanassche, Peter Verhamme |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | HemaSphere |
| Online Access: | https://doi.org/10.1002/hem3.70143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epidemiology of Venous Thromboembolism in Belgium: A Cohort Study
by: Andreas Verstraete, et al. -
Pharmacological prophylaxis of venous thromboembolism in surgical patients
by: С.І. Саволюк, et al.
Published: (2024-12-01) -
Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK
by: Emilie Clay, et al.
Published: (2018-01-01) -
Intercontinental variations in the presentation and management of venous thromboembolism
by: Cassius Iyad Ochoa Chaar, MD, MS, et al.
Published: (2025-01-01) -
Venous thromboembolic complications
by: G. G. Khubulava, et al.
Published: (2019-02-01)